NewsResearchStill Time To Participate In UK Medical Cannabis Trial

Still Time To Participate In UK Medical Cannabis Trial

-

EUROPE’S largest ever medical cannabis trial is still recruiting patients as it looks to gather further evidence to support its wider adoption.

Known as Project 21, the two-year trial was launched by Britain’s former Drugs Czar Prof David Nutt. He is seeking to recruit 20,000 patients.

Project 21’s partners include the United Patients Alliance and The Royal College of Psychiatrists (RCP), with the aim of creating the largest European medical cannabis body of evidence.

It is being backed by three medical cannabis businesses – Italian company Althea and UK, Firms Alta-Flora and Canuba – who will supply subsidised cannabis medicine.

The trial will focus on a number of conditions including; chronic pain, epilepsy, multiple sclerosis, post-traumatic stress disorder, Tourette’s syndrome, anxiety disorder or who have had a history of substance misuse.

Patients Are Forced to Break Law

Prof Nutt stated that up until 1971 cannabis had been used as a medicine in the UK for over a century before ‘it was banned for political reasons’

“Since then hundreds of thousands of patients have been forced to break the law to get a treatment that most find preferable to their previous prescription medicines,” he said.

He said Project 21 will provide a ‘solid clinical database from which experience of and confidence in, medical cannabis prescribing will develop, providing a foundation for other medical prescribers to build on’.

Professor Wendy Burn, the RCP president  said it hopes the trial will ‘address the paucity of evidence’ for the use of cannabis-based medicine.

Dr Arun Bhaskar, President of the British Pain Society said some 28m people in the UK will at some stage, suffer from chronic pain.

“Data from several countries reveal that medical cannabis have benefited several thousands of patients,”he added.

Prof Nutt, dismissed by the UK Government for saying alcohol and tobacco are more dangerous to health than ecstasy, LSD and cannabis, went on to form Drugs Science – an independent, science-led drugs charity.

For information on how to participate in the trial visit: https://drugscience.org.uk/project-twenty21/


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

New French Hemp Rules Under-fire Over Proposals To Outlaw CBD Flowers

THE French government is pressing ahead with moves to outlaw the sale of CBD flowers despite recent decisions to...

UK CBD Brand OTO Signs Deal With Synthetic CBD Brand Pureform Global

LONDON-based wellness and CBD brand, OTO, have signed a partnership deal with Pureform Global. This groundbreaking partnership will enable...

Significant Year-On-Year Rise In German Medical Cannabis Flower Imports

DESPITE a decline in cannabis flower imports for the first quarter of 2021 the German medical cannabis market continues...

Low-Cost Medical Cannabis Flowers To Be Exported From Colombia For The First Time

COLOMBIA is set to permit the export of medical cannabis flower for the first time in what could be...

UK Cannabis Business Eco Equity Announces 100% Equity Acquisition By US Firm Virtual Medical International

ECO Equity Limited a UK company with cultivation assets in Africa, will combine its operations with Virtual Medical International...

New Amendments Could Delay Passing Of Greek Medical Cannabis Bill Until Next Year

GREEK businesses are preparing for amendments to the Mediterranean country’s cannabis laws allowing the cultivation, sale and export of...

Must read

New French Hemp Rules Under-fire Over Proposals To Outlaw CBD Flowers

THE French government is pressing ahead with moves to...

Low-Cost Medical Cannabis Flowers To Be Exported From Colombia For The First Time

COLOMBIA is set to permit the export of medical...

You might also likeRELATED
Recommended to you